T cell therapy shows persistent benefits in young leukemia patients – Science Daily
Journal of Clinical Pathways |
T cell therapy shows persistent benefits in young leukemia patients
Science Daily "This expanded, global study of CAR T-cell therapy gives us further evidence of how remarkable this treatment can be for our young patients in whom all other treatments failed," said lead author Shannon L. Maude, MD, PhD, a pediatric oncologist at CHOP … The CAR–T Breakthrough: More Than Just Another Treatment Option |
